Heartseed
Signal active
Organization
Contact Information
Overview
Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
About
Industries
Biotechnology, Health Care, Medical, Beauty, Nursing and Residential Care
Founded
2015
Employees
11-50
Headquarters locations
Asia
Social
N/A
Profile Resume
Heartseed headquartered in Asia, operates in the Biotechnology, Health Care, Medical, Beauty, Nursing and Residential Care sector. The company focuses on Biotechnology and has secured $10.4B in funding across 120 round(s). With a team of 11-50 employees, Heartseed is actively contributing to advancements in Biotechnology. Their latest funding round, Series D - Heartseed, raised $14.3M. Discover more about their projects, partnerships, and impact on our platform.
Employees
Takehiko Kaneko
Director in charge of development Chief Medical Officer General Manager of R &D Division
Funding Rounds
Funding rounds
6
Investors
9
Lead Investors
0
Total Funding Amount
$86.3M
Details
5
Heartseed has raised a total of $86.3M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2016 | Seed | 878.6K | ||
| 2018 | Early Stage Venture | 7.2M | ||
| 2021 | Late Stage Venture | 37.0M | ||
| 2023 | Late Stage Venture | 14.3M |
Investors
Heartseed is funded by 31 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Arcus Investment | - | FUNDING ROUND - Arcus Investment | 14.3M |
| KOEI TECMO CAPITAL | - | FUNDING ROUND - KOEI TECMO CAPITAL | 14.3M |
| Heartseed | - | FUNDING ROUND - Heartseed | 14.3M |
| Sumitomo Mitsui Trust Investment | - | FUNDING ROUND - Sumitomo Mitsui Trust Investment | 14.3M |
Recent Activity
There is no recent news or activity for this profile.